Information  X 
Enter a valid email address

Dr. Martens PLC (DOCS)

  Print   

Thursday 29 July, 2021

Dr. Martens PLC

Result of AGM

RNS Number : 9475G
Dr. Martens PLC
29 July 2021
 

 

29 July 2021

DR. MARTENS PLC

RESULT OF ANNUAL GENERAL MEETING

29 JULY 2021

The Company announces the results of voting at its Annual General Meeting held earlier today and confirms that all resolutions were duly passed on a poll with majorities as set out below.

Resolutions 1 to 15 were proposed as Ordinary Resolutions and resolutions 16 to 19 as Special Resolutions.

Resolution

 

 

 

Votes
For

 

 

%

 

 

Votes Against

 

 

%

 

 

Votes
Total

 

 

Votes Withheld

 

% Voting

Capital Instructed

01

Receive the 2021 Annual Report and Accounts

817,208,045

100.00

918

0.00

817,208,963

286,712

81.72

02

Approve the Directors' Remuneration Report

814,391,695

99.62

3,102,787

0.38

817,494,482

1,193

81.75

03

Approve the Directors' Remuneration Policy

810,983,185

99.20

6,512,215

0.80

817,495,400

275

81.75

04

Re-elect Paul Mason

806,609,792

98.88

9,174,649

1.12

815,784,441

1,711,234

81.58

05

Re-elect Kenny Wilson

817,096,714

99.95

398,961

0.05

817,495,675

0

81.75

06

Re-elect Jon Mortimore

814,242,068

99.60

3,253,607

0.40

817,495,675

0

81.75

07

Re-elect Ian Rogers

817,494,757

100.00

918

0.00

817,495,675

0

81.75

08

Re-elect Ije Nwokorie

817,255,580

99.97

240,095

0.03

817,495,675

0

81.75

09

Re-elect Lynne Weedall

817,090,814

99.95

404,861

0.05

817,495,675

0

81.75

10

Re-elect Robyn Perriss

809,080,897

98.97

8,414,778

1.03

817,495,675

0

81.75

11

Re-elect Tara Alhadeff

808,826,724

98.94

8,668,033

1.06

817,494,757

918

81.75

12

Re-appoint Ernst & Young LLP as auditor

804,325,726

98.39

13,169,949

1.61

817,495,675

0

81.75

13

Authorise the Audit & Risk Committee to determine the Auditor's remuneration

812,881,504

99.44

4,613,253

0.56

817,494,757

918

81.75

14

Authorise the Company and its subsidiaries to make political donations

810,400,742

99.13

7,094,933

0.87

817,495,675

0

81.75

15

Authorise allotment of shares

785,256,734

96.06

32,238,941

3.94

817,495,675

0

81.75

16

Authorise general disapplication of pre-emption rights*

817,427,469

99.99

68,206

0.01

817,495,675

0

81.75

17

Authorise additional disapplication of pre-emption rights*

813,744,825

99.54

3,750,850

0.46

817,495,675

0

81.75

18

Authorise purchase of own shares*

817,175,338

99.99

100,592

0.01

817,275,930

219,745

81.73

19

Authorise calling of general meetings on 14 days' notice*

800,175,664

97.88

17,320,011

2.12

817,495,675

0

81.75

*Special Resolution


The votes of independent shareholders on the resolutions concerning the election or re-election of the Independent Non-Executive Directors are set out below:

Resolution

 

 

Votes
For

 

%

 

Votes Against

 

%

 

Votes
Total

 

Votes Withheld

 

% Independent

Capital Instructed

07

Re-elect Ian Rogers

388,352,317

100.00%

918

0.00%

388,353,235

0

68.03

08

Re-elect Ije Nwokorie

388,113,140

99.94%

240,095

0.06%

388,353,235

0

68.03

09

Re-elect Lynne Weedall

387,948,374

99.90%

404,861

0.10%

388,353,235

0

68.03

10

Re-elect Robyn Perriss

379,938,457

97.83%

8,414,778

2.17%

388,353,235

0

68.03

 

Notes:

1.  Votes "For" and "Against" are expressed as a percentage of votes received.

2.  A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

3.  As at 6.30pm on 27 July 2021 the Company had a total of 1,000,000,100 ordinary shares with voting rights in issue. The total independent voting capital, used to calculate the votes of independent shareholders on resolutions 7-10, was 570,857,660.

4.  In accordance with Listing Rule 9.6.2R, copies of the resolutions passed as special business will shortly be available for inspection on the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.  

 

Enquiries

Investors and analysts  

Bethany Barnes, Director of Investor Relations  +44 7825 187465

                                                                                                     [email protected]

Media   

Finsbury Glover Hering

Rollo Head, James Leviton   +44 20 7251 3801

 

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage and, six decades later, "Docs" or "DMs" are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. 

 

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250 index.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGPPUWUMUPGGPB

a d v e r t i s e m e n t